Advances in cytopathology for lung cancer. The impact and challenges of new technologies

Thoracic Surgery Clinics

Volumn 23, Issue 2, 2013, Pages 163-178

  Sekhon, Harmanjatinder S ^a   Souza, Carolina A ^a   Gomes, Marcio M ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cytology; Fine needle aspiration biopsy; Immunohistochemistry; Lung cancer

Indexed keywords

BEVACIZUMAB; CRIZOTINIB; CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; ERLOTINIB; GEFITINIB; NAPSIN; PEMETREXED; PROTEIN P63; SURFACTANT PROTEIN A; THYROID TRANSCRIPTION FACTOR 1; TUMOR MARKER; UNCLASSIFIED DRUG;

CANCER DIAGNOSIS; CANCER INVASION; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG CANCER; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MULTIDETECTOR COMPUTED TOMOGRAPHY; OVERALL SURVIVAL; PLEURA FLUID; PRIORITY JOURNAL; REVIEW;

ADENOCARCINOMA; BIOPSY, FINE-NEEDLE; CARCINOMA, SQUAMOUS CELL; ENDOSONOGRAPHY; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; LYMPH NODES; MALE; MEDIASTINUM; MULTIDETECTOR COMPUTED TOMOGRAPHY;

EID: 84875904665     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2013.01.011     Document Type: Review

References (40)

1. Yao X., Gomes M.M., Tsao M.S., et al. Fine-needle aspiration biopsy versus core-needle biopsy in diagnosing lung cancer: a systematic review. Curr Oncol 2012, 19:e16-e27.
2. Li H., Boiselle P.M., Shepard J.O., et al. Diagnostic accuracy and safety of CT-guided percutaneous needle aspiration biopsy of the lung: comparison of small and large pulmonary nodules. AJR Am J Roentgenol 1996, 167:105-109.
3. Oikonomou A., Matzinger F.R., Seely J.M., et al. Ultrathin needle (25 G) aspiration lung biopsy: diagnostic accuracy and complication rates. Eur Radiol 2004, 14:375-382.
4. Khouri N.F., Stitik F.P., Erozan Y.S., et al. Transthoracic needle aspiration biopsy of benign and malignant lung lesions. AJR Am J Roentgenol 1985, 144:281-288.
5. Cox J.E., Chiles C., McManus C.M., et al. Transthoracic needle aspiration biopsy: variables that affect risk of pneumothorax. Radiology 1999, 212:165-168.
6. Ohno Y., Hatabu H., Takenaka D., et al. CT-guided transthoracic needle aspiration biopsy of small (< or = 20 mm) solitary pulmonary nodules. AJR Am J Roentgenol 2003, 180:1665-1669.
7. Travis W.D., Brambilla E., Noguchi M., et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011, 6:244-285.
8. Naidich D.P., Bankier A.A., Macmahon H., et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013, 266:304-317.
9. Yasufuku K., Chiyo M., Koh E., et al. Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer 2005, 50:347-354.
10. ASGE Standards of Practice Committee, Jue T.L., Sharaf R.N., Appalaneni V., et al. Role of EUS for the evaluation of mediastinal adenopathy. Gastrointest Endosc 2011, 74:239-245.
11. Devereaux B.M., Leblanc J.K., Yousif E., et al. Clinical utility of EUS-guided fine-needle aspiration of mediastinal masses in the absence of known pulmonary malignancy. Gastrointest Endosc 2002, 56:397-401.
12. Yasufuku K., Nakajima T., Chiyo M., et al. Endobronchial ultrasonography: current status and future directions. J Thorac Oncol 2007, 2:970-979.
13. Noguchi M., Morikawa A., Kawasaki M., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75:2844-2852.
14. Sanchez-Mora N., Presmanes M.C., Monroy V., et al. Micropapillary lung adenocarcinoma: a distinctive histologic subtype with prognostic significance. Case series. Hum Pathol 2008, 39:324-330.
15. Gaikwad A., Gupta A., Hare S., et al. Primary adenocarcinoma of lung: a pictorial review of recent updates. Eur J Radiol 2012, 81:4146-4155.
16. Whithaus K., Fukuoka J., Prihoda T.J., et al. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Arch Pathol Lab Med 2012, 136:155-162.
17. Khayyata S., Yun S., Pasha T., et al. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens. Diagn Cytopathol 2009, 37:178-183.
18. Mukhopadhyay S., Katzenstein A.L. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol 2011, 35:15-25.
19. Terry J., Leung S., Laskin J., et al. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am J Surg Pathol 2010, 34:1805-1811.
20. Rekhtman N., Ang D.C., Sima C.S., et al. Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. Mod Pathol 2011, 24:1348-1359.
21. Noh S., Shim H. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: a tissue microarray study of poorly differentiated areas. Lung Cancer 2012, 76:51-55.
22. Ferlay J., Shin H.R., Bray F., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
23. Li H., Pan Y., Li Y., et al. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose. Lung Cancer 2013, 79:8-13.
24. Rosell R., Moran T., Queralt C., et al. Spanish Lung Cancer G: screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009, 361:958-967.
25. An S.J., Chen Z.H., Su J., et al. Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status. PloS One 2012, 7:e40109.
26. Shaw A.T., Yeap B.Y., Mino-Kenudson M., et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol 2009, 27:4247-4253.
27. Ammanagi A.S., Dombale V.D., Miskin A.T., et al. Sputum cytology in suspected cases of carcinoma of lung (sputum cytology a poor man's bronchoscopy!). Lung India 2012, 29:19-23.
28. Pue C.A., Pacht E.R. Complications of fiberoptic bronchoscopy at a university hospital. Chest 1995, 107:430-432.
29. Karahalli E., Yilmaz A., Turker H., et al. Usefulness of various diagnostic techniques during fiberoptic bronchoscopy for endoscopically visible lung cancer: should cytologic examinations be performed routinely?. Respiration 2001, 68:611-614.
30. Popp W., Rauscher H., Ritschka L., et al. Diagnostic sensitivity of different techniques in the diagnosis of lung tumors with the flexible fiberoptic bronchoscope. Comparison of brush biopsy, imprint cytology of forceps biopsy, and histology of forceps biopsy. Cancer 1991, 67:72-75.
31. Kawan E., Ulrich W., Redtenbacher S., et al. Kawan bronchial brush/cell block technique. Facilitation of the routine diagnosis of bronchial neoplasms. Acta Cytol 1998, 42:1409-1413.
32. van der Drift M.A., van der Wilt G.J., Thunnissen F.B., et al. A prospective study of the timing and cost-effectiveness of bronchial washing during bronchoscopy for pulmonary malignant tumors. Chest 2005, 128:394-400.
33. Sompradeekul S., Chinvetkitvanich U., Suthinon P., et al. Difference in the yields of bronchial washing cytology before and after forceps biopsy for lung cancer diagnosis. J Med Assoc Thai 2006, 89(Suppl 5):S37-S45.
34. Schreiber G., McCrory D.C. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 2003, 123:115S-128S.
35. Bielsa S., Panades M.J., Egido R., et al. An Med Interna 2008, 25:173-177. [in Spanish].
36. Lee B.E., Kletsman E., Rutledge J.R., et al. Utility of endobronchial ultrasound-guided mediastinal lymph node biopsy in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 2012, 143:585-590.
37. Yasufuku K., Pierre A., Darling G., et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg 2011, 142:1393-1400.e1.
38. Srinivasan R., Bhutani M.S., Thosani N., et al. Clinical impact of EUS-FNA of mediastinal lymph nodes in patients with known or suspected lung cancer or mediastinal lymph nodes of unknown etiology. J Gastrointestin Liver Dis 2012, 21:145-152.
39. Vimpeli S.M., Saarenmaa I., Huhtala H., et al. Large-core needle biopsy versus fine-needle aspiration biopsy in solid breast lesions: comparison of costs and diagnostic value. Acta Radiol 2008, 49:863-869.
40. Greif J., Marmor S., Schwarz Y., et al. Percutaneous core needle biopsy vs. fine needle aspiration in diagnosing benign lung lesions. Acta Cytol 1999, 43:756-760.